Skip to main content
. 2021 Apr 17;11(3):751–767. doi: 10.1007/s13555-021-00525-9
Even though melanoma represents a small percentage of all cutaneous cancers, it is responsible for most deaths from skin cancers
The survival rate at 5 years for localized melanoma is 98.3% while for metastatic melanoma (MM) is 16%
In the last decade melanoma clinical research has completely changed the scenario of therapeutic approaches for patients with unresectable advanced melanoma
Multiple targets for drug development have been identified to treat advanced melanoma and are currently undergoing development